Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
04/2005
04/28/2005US20050090555 Compound for the treatment of metabolic disorders
04/28/2005US20050090552 Crystalline form with xray powder diffraction pattern peaks at 4.7, 7.4, 13.8 and 17.0+-0.2 but not at 3.8+-0.2 theta; thermal stability
04/28/2005US20050090514 Cool-genic compounds as anticarcinogenic agents promoting apoptosis and inhibit angiogenesis; antiproliferative agents
04/28/2005US20050090381 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
04/28/2005US20050089493 Spermine peptide surfactants with amide or amine bonds for surfactants used to transfer cells
04/27/2005EP1526134A2 Triazolyl tropane derivatives as ccr5 modulators
04/27/2005EP1526128A2 Process the preparation of alpha-hydroxycarboxylic acid amides
04/27/2005EP1525186A1 Inhibitors of hcv ns5b polymerase
04/27/2005EP1525184A1 Flavourant compounds
04/27/2005EP1525183A1 Inhibitors of hcv ns5b polymerase
04/27/2005CN1610688A Ortho substituted chiral phosphines and phosphinites and their use in asymmetric catalytic reactions
04/27/2005CN1610668A Substituted propane-1, 3-diamine derivatives and the pharmaceutical use
04/27/2005CN1609098A Dimethylformamide synthesis via reactive distillation of methyl formate and dimethylaminei9u
04/27/2005CN1198823C Phenyl substituted 4-hydroxy tetrahydropyridone
04/27/2005CN1198802C Chalcones having antiproliferactive activity
04/27/2005CN1198794C Stable lysine solution
04/26/2005US6884906 Reacting carboxyalkyleneoxamenthol in inert solvent with a tert-amine base, then mixing resulting product with an oxalyl dihalide to form an intermediate, amidating intermediate with an amine
04/26/2005US6884899 Preparation of 1-amino-4-hydroxyanthraquinones
04/26/2005US6884821 Alkyloxypropanoic acid derivative containing sulfonamide or amide group are useful as insulin resistance agent
04/26/2005US6884815 An amino compound containing imidazole and aromatic, or heteroaromatic rings is useful for treating inflammatory and immune system disorders
04/26/2005CA2131182C Method for making intermediates useful in synthesis of retroviral protease inhibitors
04/26/2005CA2053253C New aryl-and heteroarylethenylene derivatives and process for their preparation
04/21/2005WO2005035514A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
04/21/2005WO2005034940A2 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
04/21/2005WO2005021472A3 Fluoridation of electron rich aromatic systems
04/21/2005WO2005020882A3 Compound capable of binding s1p receptor and pharmaceutical use thereof
04/21/2005WO2005004803A3 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
04/21/2005WO2004062601A3 Antibacterial agents
04/21/2005US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
04/21/2005US20050085662 Process for the synthesis of nacyl-2-amino-4-alkoxy-5-nitrobenzoic acids
04/21/2005US20050085652 Trans configuration; reacting 3-methyl butyric acid with halvaleric acid; forming 8-methyl-6-nonynoic acid; reduction; activation; acylation
04/21/2005US20050085630 Photocleavable isotope-coded affinity tags
04/21/2005US20050085544 Alkylation a cyanoester with dibromopropane; cyclization
04/21/2005US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
04/21/2005US20050085516 2-W-diaminocarboxylic acid compounds
04/21/2005US20050084506 Amide compounds such as (R)-methyl 2-(3-chloro-4-methoxybenzamido)-4-methylpentanoate and urea compounds such as 1-(2-chlorophenyl)-3-(heptan-4-yl)urea for modulating taste of food or drug products
04/21/2005CA2540978A1 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
04/20/2005EP1307425B1 Novel n-(2-phenyl-3-aminopropyl)naphtamides
04/20/2005EP1165495B1 Resorcinol derivatives
04/20/2005CN1608074A P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
04/20/2005CN1608055A Compounds for the treatment of metabolic disorders
04/19/2005US6881845 Reacting p-fluoroacetophenone with formaldehyde and methylbenzylamine, then hydrogenation, cyclization and reducing to form chemical intermediates for paroxetine and omiloxetine
04/19/2005US6881843 Process for production of gabapentin intermediate
04/19/2005US6881755 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
04/19/2005US6881754 Adamantane derivatives
04/14/2005WO2005033180A1 Aspartate derivatives and process for their preparation
04/14/2005WO2005033063A2 Melanin concentrating hormone antagonists
04/14/2005WO2005033062A1 Processes for the production of carboxylic acid amides and derivatives thereof
04/14/2005WO2004110374A3 3,4-disubstituted benzamidines and benzylamines, and analogues thereof, useful as serine protease inhibitors
04/14/2005US20050080121 for example, 4S-[(naphthalene-2-carbonyl)-amino]-5-(2-oxo-pyrrolidin-3S-yl)-pent-2-enoic acid ethyl ester; treatment of viral infections caused by human rhinoviruses, human polioviruses, human coxsackieviruses, human echoviruses, among others
04/14/2005US20050080119 Diaminopropionic acid derivatives
04/14/2005US20050080067 Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
04/14/2005US20050080047 Chiral diphosphorus compounds and their transition metal complexes
04/14/2005CA2540826A1 Melanin concentrating hormone antagonists
04/14/2005CA2540660A1 Aspartate derivatives and process for their preparation
04/13/2005EP1522855A2 Process for the identification of pesticidal agents
04/13/2005EP1521794A1 Weatherable polycarbonates comprising oxanilide structural units, method, and articles made therefrom
04/13/2005EP1521735A2 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
04/12/2005US6878833 Tetraalkylammonium alkoxides
04/12/2005US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough
04/12/2005US6878721 Beta2-adrenoceptor agonists
04/12/2005US6878718 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
04/07/2005WO2005030780A1 Fluorescent labeled sphingosines
04/07/2005WO2005030705A1 Inhibitors of histone deacetylase
04/07/2005WO2005030704A1 Inhibitors of histone deacetylase
04/07/2005WO2005030702A1 Biphenyloxy-acids
04/07/2005WO2005030699A1 Substituted benzanilide compound and pest control agent
04/07/2005WO2005030678A2 AMINO-SUBSTITUTED ETHYLAMINO β2 ADRENERGIC RECEPTOR AGONISTS
04/07/2005WO2005019147A3 Pesticidally active phenol derivatives
04/07/2005WO2005014533A3 Aryl and heteroaryl compounds, compositions, and methods of use
04/07/2005WO2005012260A3 Synthetic method for the preparation of quinazolin-4-one derivative
04/07/2005US20050075513 Method for preparing nitrogen-containing compounds
04/07/2005US20050075476 Process for preparing aspartates
04/07/2005US20050075400 Crystal structure; comminution in solvent; recovering; crystallization; antidiabetic agents
04/07/2005US20050075394 Phenethanolamine derivatives for treatment of respiratory diseases
04/07/2005US20050075378 Modulators of peroxisome proliferator activated receptors (ppar)
04/07/2005US20050075377 Compounds for elevating plasma lipid levels with prodrugs for humans and other mammals
04/07/2005US20050075368 Solvent extracting natural E2,E4-decadienal and undecadienal from ground, dried fruit of piper species; oxidation, esterification and transamidation; taste and aroma enhancers; bactercidel, fungicide and insecticidide activity
04/07/2005US20050075367 Ester compound and medicinal use thereof
04/07/2005US20050075324 Melanin concentrating hormone antagonists
04/07/2005US20050075271 Crystalline beta2 adrenergic receptor agonist
04/07/2005US20050074533 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
04/07/2005DE10353116A1 Herstellung von N-Acylverbindungen Preparation of N-acyl compounds
04/07/2005CA2539250A1 Biphenyloxy-acids
04/07/2005CA2539117A1 Inhibitors of histone deacetylase
04/07/2005CA2538037A1 Amino-substituted ethylamino .beta.2 adrenergic receptor agonists
04/06/2005EP1520850A2 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
04/06/2005EP1519964A2 Polymeric photoinitiators
04/06/2005EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators
04/06/2005EP1519913A1 Phenyl benzamides
04/06/2005EP1227809B1 Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
04/06/2005CN1604891A Improved methods of ortho alkylation
04/06/2005CN1603299A Novel carboxylate herbicides
04/06/2005CN1195738C 2'-substd. 1, 1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds
04/06/2005CN1195733C Method for preparation of aryl alkyl hydrogen peroxide
04/05/2005US6875850 Reagent for labelling nucleic acids
03/2005
03/31/2005WO2005028432A1 Hyperbranched (pamam) polymers via a one pot process
03/31/2005WO2005028421A2 Process for the synthesis of 6-amino-4-[(3-chloro-4-fluorophenyl)amino]-7-ethoxy-quinoline-3-carbonitrile
03/31/2005WO2005028420A1 Production of n-acyl compounds
03/31/2005WO2005016867A3 Anthranilic acid derivatives and their use as activators of the hm74a receptor